Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:200-205
Published online before print October 16, 2008, doi: 10.1161/STROKEAHA.108.523035
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/1/200    most recent
STROKEAHA.108.523035v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodriguez-Colon, S. M.
Right arrow Articles by Liao, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodriguez-Colon, S. M.
Right arrow Articles by Liao, D.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Metabolic Syndrome
*Stroke
Related Collections
Right arrow Lipids
Right arrow Obesity
Right arrow Cerebrovascular disease/stroke
Right arrow Risk Factors
Right arrow Glucose intolerance
Right arrow Acute Cerebral Infarction
Right arrow Epidemiology

(Stroke. 2009;40:200.)
© 2009 American Heart Association, Inc.


Original Contributions

Metabolic Syndrome Clusters and the Risk of Incident Stroke

The Atherosclerosis Risk in Communities (ARIC) Study

Sol M. Rodriguez-Colon, MS; Jingping Mo, MD, PhD; Yinkang Duan, MD; Jiahao Liu, MD; Joanne E. Caulfield, MS; Xuejuan Jin, MD Duanping Liao, MD, PhD

From Department of Public Health Sciences (S.M.R.-C., Y.D., J.L., J.E.C., X.J., D.L.), Pennsylvania State University College of Medicine, Hershey, Pa; Pfizer Inc (J.M.), New York, NY.

Correspondence to Sol Rodriguez-Colon, Department of Public Health Sciences, The Pennsylvania State University College of Medicine, A210, 600 Centerview Dr, Hershey, PA 17033. E-mail smr359{at}psu.edu

Background and Purpose— Little is known about the metabolic syndrome (MetS) and the risk of incident stroke. This study is designed to identify particular clusters of MetS components that carry the highest risk of incident stroke.

Methods— We analyzed the public use data from the population-based Atherosclerosis Risk in Communities study. At baseline, 14 993 stroke-free middle-aged individuals were followed-up over 9 years for incident stroke. MetS components were defined according to the National Heart, Lung, and Blood Institute/American Heart Association criteria. Incident stroke was identified using a standardized incident events identification and classification protocol. Proportional hazard models were used to assess the RRs and 95% CIs of ischemic stroke associated with MetS and its different clusters.

Results— At baseline, the prevalence of MetS was 39%. The mean age was 54, with 26% blacks and 55% females. The hazard ratio of incident ischemic stroke associated with MetS among women (hazard ratio, 2.41; 95% CI, 1.69 to 3.49) and men (hazard ratio, 2.11; 95% CI, 1.56–2.85) was similar. There was a dose–response relationship between the numbers of MetS components and the risk of incidence stroke. Persons with either elevated blood pressure or elevated fasting glucose in the clusters to form a MetS had the highest risk for incident stroke (hazard ratio, 2.74–4.16 comparing to the reference group) than MetS without these 2 components (hazard ratio, ≤2.00 comparing to the reference group).

Conclusions— The data support the need to target MetS, especially MetS, with these 2 highest risk components (elevated blood pressure or elevated fasting glucose) in the clusters.


Key Words: atherosclerosis • cohort study • metabolic syndrome • stroke risk factors




This article has been cited by other articles:


Home page
Mayo Clin Proc.Home page
S. A. Aldasouqi and V. V. Gossain
Revisiting Screening for Type 2 Diabetes Mellitus: To Screen or Not to Screen, That Is the Question
Mayo Clin. Proc., April 1, 2009; 84(4): 384 - 384.
[Full Text] [PDF]


Home page
StrokeHome page
S. Cronin and P. J. Kelly
Stroke and the Metabolic Syndrome in Populations: The Challenge Ahead
Stroke, January 1, 2009; 40(1): 3 - 4.
[Full Text] [PDF]